Eastman Chemical (NYSE: EMN) reported Q4 EPS of $1.87, $0.26 better than the analyst estimate of $1.61. Revenue for the quarter came in at $2.25 billion versus the consensus estimate of $2.28 billion.

GUIDANCE:

Eastman Chemical sees FY2025 EPS of $8.00-$8.75, versus the consensus of $8.46.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.